NL-OMON30375尚未招募不适用
Monitoring of exhaled nitric oxide (FENO) to tailor the lowest effective dose of oral corticosteroids in severe asthma - MONOSA-study
适应症
试验速览
- 阶段
- 不适用
- 状态
- 尚未招募
- 入组人数
- 100
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •- 18-65 years
- •- pulmonologist's diagnosis of severe asthma
- •- daily or alternate day oral corticosteroid therapy for at least 1 month before entering into the study
- •- maintenance high dose inhaled corticosteroids (at least 1600 mcg/day beclomethasone equivalent) and long- and short acting bronchodilators for more than one year
排除标准
- •- The patient is not able to perform adequate measurements of FENO at home
- •- The patient has no mobile phone or internet access
研究者
相似试验
已完成
不适用
Monitoring of exhaled nitric oxide (FENO) to tailor the lowest effective dose of oral corticosteroids in severe asthma (MONOSA-Study).1. Severe asthma<br /> 2. corticosteroids<br />3. adverse effects<br />4. nitric oxide.<br /> (NLD: Ernstig astma, corticosteroid, bijwerkingen, stikstofoxide).NL-OMON19976Academic Medical Center, Amsterdam University;Medical Center Leeuwarden ;Haga Ziekenhuis den Haag;Medisch Spectrum Twente;Leiden University Medical Center100
已完成
不适用
Can monitoring exhaled nitric oxide levels in outpatients improve the management of children with asthma?AsthmaRespiratoryISRCTN50872816niversity of Southampton (UK)93
招募中
不适用
itric Oxide Laboratory Animal Allergy StudyAsthmaACTRN12605000343606ACC New Zealand50
招募中
不适用
Clinical Application of exhaled Nitric Oxide measurements in PrimarY careAsthmaRespiratory - AsthmaACTRN12605000354684niversity of Otago200
已完成
3 期
se of exhaled nitric oxide levels in predicting response to oral steroids in patients with COPDChronic obstructive pulmonary disease (COPD)Respiratory - Chronic obstructive pulmonary diseaseACTRN12605000683639Health Research Council of New Zealand50